Icon

LYVISPAH (nda215422)- (5MG/PACKET,10MG/PACKET,20MG/PACKET)

BACLOFEN AMNEAL
5MG/PACKET,10MG/PACKET,20MG/PACKET
No No
2041-Sep-29 Expired
None None
None No
LYVISPAH is a gamma-aminobutyric acid (GABA-ergic) agonist indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. • LYVISPAH may also be of some value in patient with spinal cord injuries and other spinal cord diseases.
0 0 0
Total Other Developers 1
Drugs with Suitability No
5MG/PACKET ** ** - - -
10MG/PACKET ** ** - - -
20MG/PACKET ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.